LFLuciano Folador

Luciano Folador

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Luciano Folador has a total of 51 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Primary Pericardial Angiosarcoma Complicated by Constrictive Pericarditis

    by Guilherme Augusto Reissig Pereira, Maiane Maria Pauletto, Anna Paula Tscheika, Fabrício Michalski Velho, Luciano Folador

    Introduction Secondary malignant cardiac tumors are metastases from primary tumors and 22 to 132 times more common than primary cardiac tumors (PCTs).– PCTs are rare, with an estimated autopsy prevalence of 0.001-0.03%, and mostly (90%) benign., Among PCTs, cardiac angiosarcoma is a rare subtype of soft tissue sarcoma and the most common primary malignant tumor of the heart. Angiosarcomas consist of irregularly shaped vascular channels lined by anaplastic epithelial cells with substantial areas of necrosis and hemorrhage. Cardiac angiosarcoma is [...] Introduction Secondary malignant cardiac tumors are metastases from primary tumors and 22 to 132 times more common than primary cardiac tumors (PCTs).– PCTs are rare, with an estimated autopsy prevalence of 0.001-0.03%, and mostly (90%) benign., Among PCTs, cardiac angiosarcoma is a rare subtype of soft tissue sarcoma and the most common primary malignant tumor of the heart. Angiosarcomas consist of irregularly shaped vascular channels lined by anaplastic epithelial cells with substantial areas of necrosis and hemorrhage. Cardiac angiosarcoma is

  • Open Access

    Angiossarcoma Pericárdico Primário Complicado por Pericardite Constritiva

    by Guilherme Augusto Reissig Pereira, Maiane Maria Pauletto, Anna Paula Tscheika, Fabrício Michalski Velho, Luciano Folador

    Introdução Tumores cardíacos malignos secundários são metástases de tumores primários e 22-132 vezes mais comuns que tumores cardíacos primários (TCP).– Os TCPs são raros, com uma prevalência na autópsia estimada de 0,001-0,03%, e majoritariamente benignos., Entre os TCPs, o angiossarcoma cardíaco é um subtipo raro de sarcoma de tecido mole, e o tumor primário maligno mais comum do coração. Os angiossarcomas consistem em canais vasculares de formato irregular, revestidos por células epiteliais anaplásticas, com grandes áreas de necrose e hemorragia. [...] Introdução Tumores cardíacos malignos secundários são metástases de tumores primários e 22-132 vezes mais comuns que tumores cardíacos primários (TCP).– Os TCPs são raros, com uma prevalência na autópsia estimada de 0,001-0,03%, e majoritariamente benignos., Entre os TCPs, o angiossarcoma cardíaco é um subtipo raro de sarcoma de tecido mole, e o tumor primário maligno mais comum do coração. Os angiossarcomas consistem em canais vasculares de formato irregular, revestidos por células epiteliais anaplásticas, com grandes áreas de necrose e hemorragia.

  • Open Access

    Association between abnormalities on chest computed tomography and pulmonary function in patients with respiratory symptoms at 12 months after COVID-19

    by Luciano Folador, Vicente Bohrer Brentano, Ravena Maya Cardoso da Silva, Igor Gorski Benedetto, Marcelo Basso Gazzana, Danilo Cortozi Berton, Tiago Severo Garcia

    Objective: To assess the prevalence and type of residual lung abnormalities on chest computed tomography (CT) and pulmonary function testing (PFT) variables in patients with respiratory symptoms related to post-COVID-19 condition at 12 months of follow-up, and to analyze associations between CT findings and PFT parameters. Materials and Methods: The CT findings were evaluated by two radiologists, who calculated semiquantitative CT scores. The PFTs included spirometry, plethysmography, and the diffusing capacity of the lung for carbon monoxide. Results: Thirty-seven patients were included in the study. On CT scans of the chest acquired at 12 months of follow-up, 78.3% of the patients exhibited residual abnormalities, including reticular opacities, in 75.7%; traction bronchiectasis/bronchiolectasis, in 43.2%; and fibrosis-like findings, in 43.2%. The mean overall CT score was 9.30 ± 2.59. Patients with fibrosis-like findings had significantly lower total lung capacity (68.6% vs. 80.6% of the predicted value; p = 0.018). A moderate negative correlation was found between the overall CT score and total lung capacity (rs = −0.49; p = 0.003). Conclusion: It seems that a significant proportion of patients with respiratory symptoms related to post–COVID-19 condition demonstrate residual lung abnormalities on chest CT at 12 months of follow-up, with a substantial prevalence of fibrosis-like findings. Such abnormalities are associated with restrictive lung disease.

  • Prognostic Value of Different Thresholds for Myocardial Scar Quantification on Cardiac MRI Late Gadolinium Enhancement Images in Patients Receiving Implantable Cardioverter Defibrillators

    by Tamar Shalmon, Faisal Mhd. Dib Hamad, Laura Jimenez-Juan, Anish Kirpalani, Camila M. Urzua Fresno, Luciano Folador, Nigel S. Tan, Sheldon M. Singh, Yin Ge, Paul Dorian, et al.

    To compare the predictive value of different myocardial scar quantification thresholds using cardiac MRI for appropriate implantable cardioverter defibrillator (ICD) shock and mortality. In this retrospective, two-center observational cohort study, patients with ischemic or nonischemic cardiomyopathy underwent cardiac MRI prior to ICD implantation. Late gadolinium enhancement (LGE) was first determined visually and then quantified by blinded cardiac MRI readers using different SDs above the mean signal of normal myocardium, full-width half-maximum, and manual thresholding. The intermediate signal “gray zone” was calculated as the differences between different SDs. Among 374 consecutive eligible patients (mean age, 61 years ± 13 [SD]; mean left ventricular ejection fraction, 32% ± 14; secondary prevention, 62.7%), those with LGE had a higher rate of appropriate ICD shock or death than those without (37.5% vs 26.6%, log-rank P = .04) over a median follow-up of 61 months. In multivariable analysis, none of the thresholds for quantifying scar was a significant predictor of mortality or appropriate ICD shock, while the extent of gray zone was an independent predictor (adjusted hazard ratio per 1 g = 1.025; 95% CI: 1.008, 1.043; P = .005) regardless of the presence or absence of ischemic heart disease (P interaction = .57). Model discrimination was highest for the model incorporating the gray zone (between 2 SD and 4 SD). Presence of LGE was associated with a higher rate of appropriate ICD shock or death. Although none of the scar quantification techniques predicted outcomes, the gray zone both in infarct and nonischemic scar was an independent predictor and may refine risk stratification. Keywords: MRI, Scar Quantification, Implantable Cardioverter Defibrillator, Sudden Cardiac Death Supplemental material is available for this article. © RSNA, 2023


  • Open Access

    Impact of impaired pulmonary function on clinical outcomes in survivors of severe COVID-19 without pre-existing respiratory disease

    by Igor Gorski Benedetto, Ravena Maya Cardoso da Silva, Guilherme Moreira Hetzel, Gabriel da Silva Viana, Amanda Reis Guimarães, Luciano Folador, Vicente Bohrer Brentano, Tiago Severo Garcia, Sergio Pinto Ribeiro, Paulo de Tarso Roth Dalcin, et al.

    Objective: To investigate the impact of impaired pulmonary function on patient-centered outcomes after hospital discharge due to severe COVID-19 in patients without preexisting respiratory disease. Methods: This is an ongoing prospective cohort study evaluating patients (> 18 years of age) 2-6 months after hospital discharge due to severe COVID-19. Respiratory symptoms, health-related quality of life, lung function, and the six-minute walk test were assessed. A restrictive ventilatory defect was defined as TLC below the lower limit of normal, as assessed by plethysmography. Chest CT scans performed during hospitalization were scored for the presence and extent of parenchymal abnormalities. Results: At a mean follow-up of 17.2 ± 5.9 weeks after the diagnosis of COVID-19, 120 patients were assessed. Of those, 23 (19.2%) reported preexisting chronic respiratory diseases and presented with worse lung function and exertional dyspnea at the follow-up visit in comparison with their counterparts. When we excluded the 23 patients with preexisting respiratory disease plus another 2 patients without lung volume measurements, a restrictive ventilatory defect was observed in 42/95 patients (44%). This subgroup of patients (52.4% of whom were male; mean age, 53.9 ± 11.3 years) showed reduced resting gas exchange efficiency (DLCO), increased daily-life dyspnea, increased exertional dyspnea and oxygen desaturation, and reduced health-related quality of life in comparison with those without reduced TLC (50.9% of whom were male; mean age, 58.4 ± 11.3 years). Intensive care need and higher chest CT scores were associated with a subsequent restrictive ventilatory defect. Conclusions: The presence of a restrictive ventilatory defect approximately 4 months after severe COVID-19 in patients without prior respiratory comorbidities implies worse clinical outcomes.


  • Open Access

    Development of a customized three-dimensional airway model

    by Mateus Samuel Tonetto, Hugo Goulart de Oliveira, Andre Frotta Muller, Paulo Roberto Stefani Sanches, Luciano Folador, Felipe Soares Torres, Tiago Severo Garcia

    This study aimed to develop a customized, three-dimensional airway model based on relevant medical images, using additive manufacturing techniques. We evaluated the model’s ability to replicate the dimensions of the images acquired from the chest of a patient using multi-detector computed tomography (CT). Using dedicated software, a three-dimensional mesh was created based on the images. A multi-detector CT study of the full-scale printed three-dimensional airways model was subsequently carried out to compare its dimensions with that of the original study at four predetermined points. The observed median differences at the four points were 0.4 mm (p = 0.686), -1.3 mm (p = 0.138), 0.7 mm (p = 0.141), and 0.1 mm (p = 0.892). The intraclass correlation coefficient between the measurements made on the patient and those on the model was 0.98 (95% confidence interval: 0.96–0.99, p < 0.001). We successfully developed a three-dimensional model of the airway based on its corresponding medical images. The differences in the dimensions between the model and the original images were in line with those observed in previous studies and are presumably irrelevant for most applications.


  • Open Access

    Focal incidental upper abdominal findings on unenhanced chest computed tomography that do not require further imaging: a roadmap for the thoracic radiologist

    by Henrique Pavan, Tiago Severo Garcia, Felipe Soares Torres, Fernando Ferreira Gazzoni, Luciano Folador, Caroline Lorenzoni Almeida Ghezzi

    Chest scans usually include the upper abdomen, leading radiologists to evaluate the upper abdominal structures. The aim of this article is to summarize the most common incidental upper abdominal findings that do not require further imaging or management in patients undergoing unenhanced computed tomography of the chest for the investigation of thoracic symptoms or diseases. We review common incidental findings of the liver, gallbladder, spleen, adrenal glands, kidney, and retroperitoneum, as well as findings that mimic other lesions. Thoracic radiologists should be aware of such typical findings and report when no further investigation is needed, thus avoiding unnecessary imaging examinations, protecting patients from additional medical interventions, and allaying patient concerns.


  • Open Access

    Diagnostic performance of the RSNA-proposed classification for COVID-19 pneumonia versus pre-pandemic controls

    by Cauã O. Rocha, Tássia A.D. Prioste, Carlo S. Faccin, Luciano Folador, Mateus S. Tonetto, Pedro G. Knijnik, Natalia B. Mainardi, Rogério B. Borges, Tiago S. Garcia


  • Open Access

    Hepatopulmonary syndrome has low prevalence of pulmonary vascular abnormalities on chest computed tomography

    by Luciano Folador, Felipe S Torres, Juliana F Zampieri, Betina C Machado, Marli M Knorst, Marcelo B Gazzana

    Hepatopulmonary syndrome (HPS) is defined as an arterial oxygenation defect induced by intrapulmonary vascular dilatations associated with hepatic disease. This study aimed to assess the prevalence of type 1 and 2 pulmonary vascular abnormalities on chest computed tomography (CT) in patients with cirrhosis and HPS and to characterize intra- and interobserver reliability. Two thoracic radiologists retrospectively evaluated chest CT scans from 38 cirrhosis patients with HPS. They classified the pulmonary vascular abnormalities as type 1 (multiple dilated distal pulmonary arteries), type 2(nodular dilatation or individual pulmonary arterial malformation), or absence of abnormality. Furthermore, they measured the diameters of the central pulmonary arteries and subsegmental pulmonary arteries and bronchi. We analyzed the prevalence, intraobserver reliability, and interobserver reliability of abnormal CT findings related to HPS, and the correlation of these findings with partial arterial oxygen pressure (PaO2). The overall prevalence of pulmonary vascular abnormalities was 28.9% (95% confidence intervals: 15.4%, 45.9%). Moreover, 26.3% of patients had type 1 abnormality (13.4%, 43.1%) and 2.6% of patients had type 2 abnormality (0.0%, 13.8%). The intraobserver reliability kappa value was 0.666 (0.40, 0.91) and the interobserver kappa value was 0.443 (0.12, 0.77). There was no correlation between pulmonary vascular abnormalities on CT and PaO2 values. The prevalence of pulmonary vascular abnormalities on chest CT of patients with cirrhosis and HPS is low and not correlated with PaO2. These findings question the usefulness of chest CT for the evaluation of patients with cirrhosis and HPS.


  • Measuring Left Ventricular Size in Non–Electrocardiographic-gated Chest Computed Tomography

    by Felipe S. Torres, Luciano Folador, Diego A. Eifer, Murilo Foppa, Kate Hanneman

    Non–electrocardiographic (ECG)-gated computed tomography (CT) of the chest is one of the most commonly performed imaging studies. Although the heart is included in every CT study, cardiac findings are commonly underreported in radiology reports. Left ventricular size is one of the most important prognostic markers in multiple cardiac diseases and can be measured on almost all non–ECG-gated multidetector chest CT studies. This review will discuss the available evidence on different measurements of left ventricular size obtained on non–ECG-gated CT of the chest. Measurement thresholds, technical issues, and potential problems are emphasized, with practical recommendations.